FIRM FIXED PRICE

DAKOTA DRUG, INC. - 4569850390!CEVIMELINE HCL 30 MG CAPSULE 100S

PIID: SPE2DB26FJMNB
Signed Date: Oct 28, 2025Effective Date: Oct 28, 2025End Date: Closed on Oct 29, 2025
Award $
$1K
Vendor
DAKOTA DRUG, INC.
NAICS
424210
Signed Date
Oct 28, 2025

Key Details

Dollars Obligated
$1,008.49
Base & All Options
$1,008.49
Awarding Agency
Department of Defense
Awarding Sub-Agency
Defense Logistics Agency
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
ANOKA, MN, 553031091, CD-MN-03

Description

4569850390!CEVIMELINE HCL 30 MG CAPSULE 100S

Context & Analysis

On Oct 28, 2025, Department of Defense obligated $1,008.49 to DAKOTA DRUG, INC. for 4569850390!cevimeline hcl 30 mg capsule 100s. The award is classified under NAICS 424210 — DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in ANOKA, MN.

Contractor Information

Contractor: DAKOTA DRUG, INC.
UEI: H544BCGUKW64
CAGE Code: 42465
Location: ANOKA, MN
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related